Steno Collaborative Grants
Supports Danish diabetes collaborations led by Steno centers and partner institutions.
⚠This may reflect a past cycle — verify the current call on the funder's site.
The Steno Collaborative Grants programme is funded by the Novo Nordisk Foundation and is designed to strengthen research collaboration between Denmark's Steno Diabetes Centers and external research institutions, both within Denmark and internationally. The programme targets patient-centred and clinically relevant diabetes research across the areas of bioscience and basic biomedicine, clinical and translational medicine, and endocrinology and metabolism. Its strategic objective is to raise Denmark's international standing in diabetes prevention and care research. The 2026 cycle opened on 1 April 2026 and closes at 2:00 pm Copenhagen time on 2 June 2026, with results expected in mid-September 2026.
The total available pool for the 2026 cycle is DKK 30 million, distributed as individual grants of between DKK 1 million and DKK 10 million. Projects must run for between one and five years. Each project requires a main applicant plus two to five co-applicants. The main applicant must be employed at a Steno Diabetes Center or a Steno Partner Institution — defined as a hospital holding a formal cooperative agreement with a Steno Diabetes Center. Co-applicants may be based at hospitals, universities, municipalities, or non-profit research or diabetes care institutions in Denmark or abroad, and international collaboration is explicitly encouraged by the Foundation.
Applications are submitted through the Novo Nordisk Foundation's NORMA online system. Eligible applicant organisations include non-profits, universities, hospitals, and research organisations; for-profit companies are not eligible. Career stages supported range from clinicians and nurses through postdoctoral researchers to research leaders at all levels. The next expected call after the 2026 cycle is April 2027. The programme contact at the Foundation is Senior Grant Manager Ursula Bach (urba@novo.dk).
Collaborative, patient-centred diabetes research linking Denmark's Steno Diabetes Centers with external Danish and international research institutions across bioscience, clinical medicine, and endocrinology.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline